Torrent Pharma

₹3409.8 8.6 | 0.3%

WEBSITE BSE:500420 NSE : TORRENT PHAR 26 Dec, 16:01

Market Cap ₹115401 Cr.

Stock P/E 69.7

P/B 15.4

Current Price ₹3409.8

Book Value ₹ 221.7

Face Value 5

52W High ₹3590

Dividend Yield 0.82%

52W Low ₹ 2248.7

Edit Ratio

Torrent Pharma Research see more...

Overview Inc. Year: 1972Industry: Pharmaceuticals & Drugs

Torrent Pharmaceuticals Ltd is an India-based pharmaceutical business enterprise. The Company is engaged in studies, improvement, manufacturing and advertising of generic pharmaceutical formulations. It operates in the gastrointestinal (GI), central nervous system (CNS),therapeutic segments of cardiovascular (CV), and vitamins minerals nutritionals (VMN). It additionally has presence in therapeutic areas, consisting of anti-epileptic, anti-diabetic, anti-most cancers, anti-zits, corticosteroids and cosmeceuticals. It has developed complex formulations for global markets based totally on oral solids, injections, inhalation technologies, long-appearing depot injections ophthalmic, nasal, semisolids for outside packages and multi-particulate extended-launch oral structures. The Company is growing numerous in-house new chemical entities (NCE) inside the regions of metabolic, cardiovascular, gastrointestinal, dermatological and breathing problems. It has a presence across more than forty countries.

Torrent Pharma Share Price

New

Volume

Price

Price: NSE50 DMA200 DMAVolume

Quarterly Price

Quarterly Monthly

Show Value Show %

Peer Comparison

Torrent Pharma Quarterly Results

#(Fig in Cr.)	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024
Net Sales	2347	2291	2491	2491	2591	2660	2732	2745	2859	2889
Other Income	30	16	-10	9	34	26	-33	31	24	-16
Total Income	2377	2307	2481	2500	2625	2686	2699	2776	2883	2873
Total Expenditure	1635	1612	1767	1764	1800	1835	1863	1862	1955	1950
Operating Profit	742	695	714	736	825	851	836	914	928	923
Interest	55	69	102	107	103	91	80	80	75	64
Depreciation	155	163	193	196	191	201	213	203	197	198
Exceptional Income / Expenses	0	0	0	0	0	0	88	0	0	0
Profit Before Tax	532	463	419	433	531	559	631	631	656	661
Provision for Tax	178	151	127	146	153	173	188	182	199	208
Profit After Tax	354	312	292	287	378	386	443	449	457	453
Adjustments	0	0	0	0	0	0	0	0	0	0
Profit After Adjustments	354	312	292	287	378	386	443	449	457	453
Adjusted Earnings Per Share	10.5	9.2	8.6	8.5	11.2	11.4	13.1	13.3	13.5	13.4

Torrent Pharma Profit & Loss

#(Fig in Cr.)	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	TTM
Net Sales	4185	4653	6667	5816	5950	7673	7939	8005	8508	9620	10728	11225
Other Income	38	286	229	223	307	64	121	57	197	63	62	6
Total Income	4223	4939	6896	6039	6257	7736	8061	8061	8705	9683	10790	11231
Total Expenditure	3233	3633	3937	4438	4609	5696	5769	5524	6077	6796	7364	7630
Operating Profit	990	1306	2959	1601	1648	2040	2292	2537	2628	2887	3426	3601
Interest	59	175	184	206	308	504	451	353	255	333	354	299
Depreciation	87	191	238	307	409	618	654	658	662	707	808	811
Exceptional Income / Expenses	0	0	-194	0	0	-357	0	0	-485	0	88	88
Profit Before Tax	844	940	2343	1088	931	562	1187	1526	1226	1847	2352	2579
Provision for Tax	180	189	610	155	253	125	162	274	449	602	696	777
Profit After Tax	664	751	1733	934	678	436	1025	1252	777	1245	1656	1802
Adjustments	-0	-0	-0	-0	-0	-0	0	0	0	0	0	0
Profit After Adjustments	664	751	1733	934	678	436	1025	1252	777	1245	1656	1802
Adjusted Earnings Per Share	19.6	22.2	51.2	27.6	20	12.9	30.3	37	23	36.8	48.9	53.3

Growth Rates

#	1 Year	3 Year	5 Year	10 Year
Sales CAGR	12%	10%	7%	10%
Operating Profit CAGR	19%	11%	11%	13%
PAT CAGR	33%	10%	31%	10%

#	1 Year	3 Year	5 Year	10 Year
Share Price CAGR	49%	29%	30%	20%
ROE Average	25%	20%	21%	26%
ROCE Average	24%	20%	18%	22%

Torrent Pharma Balance Sheet

#(Fig in Cr.)	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Shareholder's Funds	1902	2491	3494	4350	4622	4724	4823	5837	5953	6198	6856
Minority's Interest	0	0	0	0	1	0	0	0	0	0	0
Borrowings	744	2185	1850	2241	4111	3913	3304	2941	2123	2496	1604
Other Non-Current Liabilities	182	320	145	62	31	-52	-5	-17	115	327	620
Total Current Liabilities	2175	2824	3285	2738	5202	5165	5454	4892	4415	5447	5425
Total Liabilities	5004	7820	8775	9392	13967	13751	13577	13653	12606	14468	14505
Fixed Assets	875	2833	2859	3688	7855	7748	7533	7065	6423	8121	8138
Other Non-Current Assets	724	936	1227	824	850	966	1062	1065	889	1018	756
Total Current Assets	3404	4051	4688	4879	5262	5038	4979	5522	5165	5314	5611
Total Assets	5004	7820	8775	9392	13967	13751	13577	13653	12606	14468	14505

Torrent Pharma Cash Flow

#(Fig in Cr.)	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Opening Cash & Cash Equivalents	687	955	612	1050	1068	702	589	662	573	398	509
Cash Flow from Operating Activities	599	810	2742	1009	894	1798	1393	2005	1803	2368	3266
Cash Flow from Investing Activities	-356	-2162	-838	-787	-4707	-241	199	-449	-197	-2415	-168
Cash Flow from Financing Activities	86	1212	-1435	-193	3417	-1314	-1549	-1651	-1781	77	-2780
Net Cash Inflow / Outflow	330	-140	469	29	-395	242	42	-95	-175	30	319
Closing Cash & Cash Equivalent	955	865	1050	1068	702	940	662	573	398	509	835

Torrent Pharma Ratios

#	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Earnings Per Share (Rs)	19.61	22.19	51.21	27.58	20.03	12.89	30.27	36.99	22.96	36.79	48.94
CEPS(Rs)	22.18	27.82	58.23	36.65	32.11	31.14	49.61	56.42	42.52	57.67	72.82
DPS(Rs)	10	11.25	17.5	14	14	17	32	35	48	22	28
Book NAV/Share(Rs)	56.21	73.58	103.23	128.52	136.56	139.58	142.5	172.45	175.87	183.13	202.57
Core EBITDA Margin(%)	22.7	21.89	40.82	23.52	11.91	13.61	14.51	16.67	15.98	17.3	20.13
EBIT Margin(%)	21.53	23.92	37.8	22.09	11.01	7.33	10.95	12.63	9.74	13.36	16.2
Pre Tax Margin(%)	20.13	20.16	35.05	18.58	8.27	3.87	7.94	10.26	8.06	11.32	14.08
PAT Margin (%)	15.84	16.11	25.92	15.94	6.02	3	6.85	8.41	5.11	7.63	9.92
Cash Profit Margin (%)	17.91	20.2	29.47	21.18	9.65	7.26	11.23	12.84	9.46	11.96	14.75
ROA(%)	15.16	11.71	20.89	10.28	5.81	3.15	7.5	9.2	5.92	9.2	11.43
ROE(%)	39.94	34.19	57.92	23.8	15.12	9.34	21.47	23.49	13.18	20.5	25.38
ROCE(%)	35.06	26.98	45.63	20.36	13.81	9.75	15.28	17.62	14.35	20.32	24.28
Receivable days	77.81	105.19	82.76	74.66	35.74	33.78	37.65	38.92	37.86	39.99	41.38
Inventory Days	84.02	81.17	66.19	90.9	57.16	49.01	49.84	59.24	61.71	52.47	49.26
Payable days	411.42	464.01	520.94	449.01	451.45	370.58	381.76	383.19	306.08	243.5	279.66
PER(x)	13.35	26.16	13.08	28.09	31.14	75.73	32.56	34.35	60.89	41.79	53.15
Price/Book(x)	4.66	7.89	6.49	6.03	4.57	6.99	6.92	7.37	7.95	8.4	12.84
Dividend Yield(%)	1.91	0.97	2.61	0.9	1.12	0.87	1.62	1.38	1.72	1.43	1.08
EV/Net Sales(x)	2.2	4.69	3.66	4.79	4.49	4.99	4.85	5.9	5.99	5.9	8.5
EV/Core EBITDA(x)	9.32	16.71	8.24	17.39	16.21	18.75	16.82	18.62	19.38	19.66	26.61
Net Sales Growth(%)	30.32	11.2	43.27	-12.77	2.31	28.96	3.47	0.82	6.29	13.07	11.51
EBIT Growth(%)	46.67	23.53	126.68	-48.82	-4.19	-14.04	53.68	14.78	-21.19	47.24	24.08
PAT Growth(%)	52.65	13.11	130.8	-46.14	-27.36	-35.66	134.86	22.17	-37.92	60.22	33.02
EPS Growth(%)	53.41	13.11	130.81	-46.14	-27.36	-35.66	134.88	22.17	-37.92	60.23	33.02
Debt/Equity(x)	0.59	1.1	0.67	0.58	1.4	1.28	1.21	0.83	0.68	0.85	0.57
Current Ratio(x)	1.57	1.43	1.43	1.78	1.01	0.98	0.91	1.13	1.17	0.98	1.03
Quick Ratio(x)	1.11	1.06	1.02	1.22	0.64	0.6	0.52	0.59	0.62	0.57	0.62
Interest Cover(x)	15.4	6.37	13.74	6.29	4.02	2.11	3.63	5.32	5.81	6.54	7.65
Total Debt/Mcap(x)	0.13	0.14	0.1	0.1	0.31	0.18	0.18	0.11	0.08	0.1	0.04

Torrent Pharma Shareholding Pattern

#	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024
Promoter	71.25	71.25	71.25	71.25	71.25	71.25	71.25	71.25	71.25	71.25
FII	10.8	11.37	12.09	12.04	12.84	13.15	14.09	14.14	14.22	14.46
DII	10.01	9.51	8.87	9	8.31	8	7.21	7.26	7.27	7.08
Public	7.95	7.88	7.8	7.71	7.6	7.6	7.45	7.36	7.26	7.21
Others	0	0	0	0	0	0	0	0	0	0
Total	100	100	100	100	100	100	100	100	100	100

#	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024
Promoter	12.06	24.11	24.11	24.11	24.11	24.11	24.11	24.11	24.11	24.11
FII	1.83	3.85	4.09	4.08	4.35	4.45	4.77	4.78	4.81	4.89
DII	1.69	3.22	3	3.05	2.81	2.71	2.44	2.46	2.46	2.4
Public	1.35	2.67	2.64	2.61	2.57	2.57	2.52	2.49	2.46	2.44
Others	0	0	0	0	0	0	0	0	0	0
Total	16.92	33.84	33.84	33.84	33.84	33.84	33.84	33.84	33.84	33.84

Pros

Company has delivered good profit growth of 30% CAGR over last 5 years
Company has reduced debt.

Cons

Debtor days have increased from 243.5 to 279.66days.
Stock is trading at 15.4 times its book value.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Torrent Pharma News

IPO

Companies	Open Date	Close Date	Issue Price	Cost of 1 Lot	GMP	Expected Listing	Listing Gain(%)	Listing Price	Current Price	Type	Exchange

Companies	Open Date	Close Date	Issue Price	Cost of 1 Lot	GMP	Expected Listing	Listing Gain(%)	Listing Price	Current Price	Type	Exchange

Companies	Open Date	Close Date	Issue Price	Cost of 1 Lot	GMP	Expected Listing	Listing Gain(%)	Listing Price	Current Price	Type	Exchange

Companies	Open Date	Close Date	Issue Price	Cost of 1 Lot	GMP	Expected Listing	Listing Gain(%)	Listing Price	Current Price	Type	Exchange

Companies	Open Date	Close Date	Issue Price	Cost of 1 Lot	GMP	Expected Listing	Listing Gain(%)	Listing Price	Current Price	Type	Exchange

Torrent Pharma

Add Watchlist

Torrent Pharma Research see more...

Overview Inc. Year: 1972Industry: Pharmaceuticals & Drugs

Torrent Pharma Share Price

Alert Data

Quarterly Price

Peer Comparison

Torrent Pharma Quarterly Results

Torrent Pharma Profit & Loss

Growth Rates

Torrent Pharma Balance Sheet

Torrent Pharma Cash Flow

Torrent Pharma Ratios

Torrent Pharma Shareholding Pattern

Torrent Pharma News

IPO

Stocx: India's #1 Marketplace to Find Your Winning Stock

Please Login!

Error!